April 01, 2025FinancialTerumo announces changes to the names of some businesses within the Cardiac and Vascular Company (PDF 117.21 KB) Disclosure segments of Blood and Cell Technologies Company to also be revised
April 01, 2025CorporateTerumo unveils "Our Promise," the long-term direction to be pursued by the entire groupThe company also launches a group brand video and visuals that express its unwavering commitment to improving patients’ lives
March 31, 2025CorporateTerumo opens new R&D center in the U.S. to strengthen global innovation capabilities
FYE 3/2024 FYE 3/2023 FYE 3/2022 FYE 3/2020 FYE 3/2019 FYE 3/2018 FYE 3/2017 FYE 3/2024 Consolidated Financial Statements (PDF 1.11 MB) FYE 3/2023 Consolidated Financial Statements (PDF 1.31 MB) Consolidated Financial Statements (PDF 1.31 MB) FYE 3/2022 Consolidated Financial Statements (PDF 1.19 MB) Consolidated Financial Statements (PDF 1.19 MB) FYE 3/2020 Consolidated Financial Statements (PDF 1.48 MB) FYE 3/2019 Consolidated Financial Statements (PDF 1.52 MB) FYE 3/2018 Consolidated Financial Statements (PDF 1.77 MB) FYE 3/2017 Consolidated Financial Statements (PDF 2.93 MB) Adobe Reader (free) is required to view PDF files. Download Adobe Reader
FYE 3/2023 Consolidated Financial Statements (PDF 1.31 MB) Consolidated Financial Statements (PDF 1.31 MB)
FYE 3/2022 Consolidated Financial Statements (PDF 1.19 MB) Consolidated Financial Statements (PDF 1.19 MB)